Radiological imaging of the neck for initial decision-making in oral squamous cell carcinomas—A questionnaire survey in the Nordic countries

References

• NORDCAN [Internet]. Association of the Nordic Cancer Registries; 2009. Available from: http://www-dep iarc fr/NORDCAN/DK/frame.asp.
   Google Scholar
• DSHHO [Internet]. Behandling af orale planocellulære karcinomer. 2009. Available from: http://www dshho dk/files/OralRefProg_24juni2003 pdf
   Google Scholar
• Layland MK, Sessions DG, Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 2005;115:629–39.
   PubMed Web of Science ®Google Scholar
• UICC. TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2009.
   Google Scholar
• Steinkamp HJ, Keske U, Schedel J, Hosten N, Felix R. [The spiral CT of cervical lymph node enlargements. The initial clinical results]. Rofo 1994;160:500–5. German.
   Google Scholar
• Available from: http://www.goscandinavia. http://goscandinavia about com/od/visatraveldocumentatio1/qt/nordicpopulation.htm. 2009.
   Google Scholar
• Kristiansen IS, Pedersen KM. [Health care systems in the Nordic countries – more similarities than differences?]. Tidsskr Nor Laegeforen 2000;120:2023–9. Norwegian.
   Google Scholar
• Bilde A, von BC, Johansen J, Bastholt L, Sorensen JA, Marker P, . The Danish national guidelines for treatment of oral squamous cell carcinoma. Acta Oncol 2006;45:294–9.
   PubMed Web of Science ®Google Scholar
• Primdahl H, Nielsen AL, Larsen S, Andersen E, Ipsen M, Lajer C, . Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: A Danish nationwide survey from DAHANCA. Acta Oncol 2006;45:156–61.
   PubMed Web of Science ®Google Scholar
• Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol 2007;84:5–10.
   PubMed Web of Science ®Google Scholar
• Kowalski LP, Carvalho AL. Influence of time delay and clinical upstaging in the prognosis of head and neck cancer. Oral Oncol 2001;37:94–8.
   PubMed Web of Science ®Google Scholar
• Sharp L, Lewin F, Hellborg H, Lundgren J, Hemmingsson E, Rutqvist LE. When does my treatment start? – The continuum of care for patients with head and neck cancer. Radiother Oncol 2002;63:293–7.
   PubMedGoogle Scholar
• Toustrup K, Lambertsen K, Birke-Sorensen H, Ulhoi B, Sorensen L, Grau C. Reduction in waiting time for diagnosis and treatment of head and neck cancer – a fast track study. Acta Oncol Epub 2011 Jan 24.
   Google Scholar
• Sundhedsstyrelsen. Pakkeforløb for hoved-hals kræft. 2009. Available from: http://www sst dk/publ/Publ2009/SUPL/Pakke_kraeft/Kraeft_hovedhals_okt09 pdf.
   Google Scholar
• de Bondt RB, Nelemans PJ, Hofman PA, Casselman JW, Kremer B, van Engelshoven JM, . Detection of lymph node metastases in head and neck cancer: A meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 2007;64:266–72.
   PubMed Web of Science ®Google Scholar
• van den Brekel MW, Castelijns JA, Snow GB. The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: How reliable is it? AJNR Am J Neuroradiol 1998;19:695–700.
   PubMed Web of Science ®Google Scholar
• Yamazaki Y, Saitoh M, Notani K, Tei K, Totsuka Y, Takinami S, . Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med 2008;22:177–84.
   PubMed Web of Science ®Google Scholar
• Zhu LJ, Chen ZW, Hou QY, Wang QP, Jiang S, Feng H, . [Clinical value of PET in identifying cervical nodal metastases of tongue cancer: a comparison with CT/MRI and clinical palpation in 38 cases]. Nan Fang Yi Ke Da Xue Xue Bao 2009;29:2228–30. Chinese.
   Google Scholar
• Liao CT, Wang HM, Huang SF, Chen IH, Kang CJ, Lin CY, . PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity. J Nucl Med 2011;52:180–7.
   PubMedGoogle Scholar
• Schroeder U, Dietlein M, Wittekindt C, Ortmann M, Stuetzer H, Vent J, . Is there a need for positron emission tomography imaging to stage the N0 neck in T1–T2 squamous cell carcinoma of the oral cavity or oropharynx? Ann Otol Rhinol Laryngol 2008;117:854–63.
   PubMedGoogle Scholar
• Seitz O, Chambron-Pinho N, Middendorp M, Sader R, Mack M, Vogl TJ, . 18F-fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: Comparison with MR imaging and validation with surgical specimen. Neuroradiology 2009;51:677–86.
   PubMed Web of Science ®Google Scholar
• Delouya G, Igidbashian L, Houle A, Belair M, Boucher L, Cohade C, . (18)F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer. Radiother Oncol Epub 2011 Aug 30.
   Google Scholar
• Schoder H, Fury M, Lee N, Kraus D. PET monitoring of therapy response in head and neck squamous cell carcinoma. J Nucl Med 2009;50(Suppl 1):74S–88.
   PubMedGoogle Scholar
• Hermans R. Diffusion-weighted MRI in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 2010;18:72–8.
   PubMedGoogle Scholar
• Fukunari F, Okamura K, Zeze R, Kagawa T, Hashimoto K, Yuasa K. Cervical lymph nodes with or without metastases from oral squamous carcinoma: A correlation of MRI findings and histopathologic architecture. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109:890–9.
   PubMedGoogle Scholar
• Genden EM, Ferlito A, Silver CE, Takes RP, Suarez C, Owen RP, . Contemporary management of cancer of the oral cavity. Eur Arch Otorhinolaryngol 2010;267:1001–17.
   PubMedGoogle Scholar